CalciMedica has terminated a Phase II study on its lead asset, Auxora (zegocractin), in acute kidney injury (AKI) with ...

CalciMedica had been evaluating the therapy, called Auxora, in the Kourage trial of patients with stage 2 or 3 AKI with ...

Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors and subsidiary of Beyond Air, Inc. (NASDAQ: ...

CalciMedica shares were 82% lower, at 91 cents, after the company said it was discontinuing its Phase 2 clinical trial evaluating Auxora in patients with Stage 2 or Stage 3 acute kidney injury with ...

For those that do survive the virus, it is noted that they often have long term neurological sequelae, including the development of epilepsy, personality changes and even the potential for a ...

Beyond Air, Inc. (NASDAQ: XAIR) ('Beyond Air” or the 'Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the ...

CalciMedica shares fell after the company stopped its Phase 2 KOURAGE trial for Auxora due to safety concerns.

Tammy Wynette expressed her everlasting love for her ex-husband, George Jones, before she died, their daughter revealed.

Laura Dern made one final vow to her mother, Diane Ladd, before her death from lung disease. “I made a promise to my mom that ...

Additionally, Beyond Cancer, Ltd., an affiliate of Beyond Air, is investigating ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumors in the pre-clinical ...

Two recent deaths at Chicago-area nursing homes highlight problem of poor care, difficulty in holding those responsible accountable, advocates say.

Investing.com -- CalciMedica Inc. (NASDAQ:CALC) stock plunged 80% Wednesday after the company announced it was discontinuing its Phase 2 KOURAGE clinical trial for acute kidney injury following safety ...